New cholesterol drug tested in 1,500 patients – does diabetes matter?
NCT ID NCT07382778
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at how well the drug Livalozet lowers bad cholesterol (LDL-C) in people with high cholesterol, comparing those with and without diabetes. Over 1,500 adults took part for 24 weeks. The main goal was to measure the change in LDL-C levels from the start of the study.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HYPERCHOLESTEROLEMIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Seoul National University Bundang Hospital
Seongnam-si, Gyeonggi-do, 13496, South Korea
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new pill tame high cholesterol?
- Ancient herbal mix put to the test against high cholesterol
- Cookies that could fight cholesterol: pumpkin seeds and walnuts put to the test
- Could a daily pill help kids with inherited high cholesterol?
- Free meds and tailored education may cut heart risks in Low-Income seniors
- Can a smartphone app help lower bad cholesterol?